The transforming growth factor-beta pathway is a common target of drugs that prevent experimental diabetic

Chiara Gerhardinger1, Zeina Dagher, Paola Sebastiani

  • 1Schepens Eye Research Institute and Department of Ophthalmology, Harvard Medical School, Boston, MA, USA. chiara.gerhardinger@schepens.harvard.edu

Diabetes
|April 30, 2009
PubMed
Abstract

Insights

Diabetic retinopathy involves oxidative stress and inflammation, primarily impacting retinal vessels. Transforming growth factor-beta (TGF-beta) and apoptosis are key targets for preventing capillary damage.

Area of Science:

  • Ophthalmology
  • Diabetology
  • Molecular Biology

Background:

  • Diabetic retinopathy (DR) is a leading cause of vision loss, driven by hyperglycemia's effects on retinal vasculature.
  • Identifying molecular targets is crucial for developing drugs to prevent DR progression.

Purpose of the Study:

  • To investigate molecular changes in retinal vessels of diabetic rats.
  • To identify potential drug targets for preventing diabetic retinopathy by examining the effects of sorbinil and aspirin.

Main Methods:

  • Gene expression profiling of retinal vessels from diabetic and control rats.
  • Analysis of transforming growth factor-beta (TGF-beta) signaling, oxidative stress, inflammation, and apoptosis.
  • Validation using real-time RT-PCR, immunoblotting, and immunohistochemistry.

Main Results:

  • Diabetic rats exhibited altered expression of TGF-beta pathway genes, oxidative stress, inflammation, and apoptosis markers in retinal vessels.
  • Sorbinil effectively normalized oxidative stress and inflammation-related gene expression.
  • Both sorbinil and aspirin reduced TGF-beta pathway and apoptosis-related gene upregulation.

Conclusions:

  • The polyol pathway significantly contributes to oxidative and inflammatory stress in diabetic retinal vessels.
  • Targeting TGF-beta signaling and apoptosis pathways holds promise for preventing diabetic retinopathy.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...